Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial
阿维鲁单抗联合阿昔替尼对比舒尼替尼作为晚期肾细胞癌患者一线治疗方案:III期JAVELIN Renal 101试验的最终分析
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2024.12.008
Choueiri, T K; Penkov, K; Uemura, H; Campbell, M T; Pal, S; Kollmannsberger, C; Lee, J L; Venugopal, B; van den Eertwegh, A J M; Negrier, S; Gurney, H; Albiges, L; Berger, R; Haanen, J B A G; Oyervides Juárez, V; Rini, B I; Larkin, J; Nolè, F; Schmidinger, M; Atkins, M B; Tomita, Y; Ellers-Lenz, B; Hoffman, J; Sandner, R; Wang, J; di Pietro, A; Motzer, R J